Diagnostic accuracy of tachypnoea for predicting mortality and identifying sepsis in young infants aged 0–59 days: a systematic review and meta-analysis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Diagnostic Precision of Tachypnoea in Forecasting Mortality and Detecting Sepsis in Infants Aged 0–59 Days: A Systematic Review and Meta-Analysis

  • By

  • Suci Ardini Widyaningsih

  • Sophie Driker

  • Alastair Fung

  • Naomi Schmeck

  • Sitarah Mathias

  • Megan Yu

  • Yasir Shafiq

  • Amber Hoey

  • Tessa Kehoe

  • Yumin Kim

  • Jana Adnan

  • Anum S Hussaini

  • Carrie G Wade

  • Anne CC Lee

  • July 2, 2026

Share

Clinical Report: Evaluating the Diagnostic Precision of Tachypnoea in Infants

Overview

This systematic review and meta-analysis evaluated the diagnostic accuracy of tachypnoea thresholds in predicting mortality and detecting sepsis in infants aged 0–59 days. Tachypnoea≥60 bpm was associated with increased odds of mortality.

Background

Tachypnoea is a critical clinical sign used to predict mortality and identify sepsis in young infants. Accurate identification of at-risk infants is essential for timely intervention, especially in low-resource settings where laboratory diagnostics may not be available.

Data Highlights

Tachypnoea Threshold

Pooled OR for Mortality

Sensitivity

Specificity

≥60 bpm

3.14 (95% CI 1.30 to 7.56)

31% (95% CI 19% to 45%)

89% (95% CI 66% to 97%)

≥70 bpm

10.06 (95% CI 2.39 to 42.35)

10.9% (95% CI 5.3 to 19.1%)

99.4% (95% CI 99.1 to 99.6%)

Key Findings

  • Tachypnoea≥60 bpm is associated with a threefold increased odds of mortality in infants.

  • The sensitivity of tachypnoea≥60 bpm for predicting mortality is 31%, with a specificity of 89%.

  • Tachypnoea≥70 bpm shows a higher odds ratio for mortality (OR 10.06) but lower sensitivity (10.9%).

  • Tachypnoea is not significantly associated with culture-confirmed sepsis.

Clinical Implications

Tachypnoea should be used as a danger sign for assessing mortality risk in young infants.

Conclusion

The findings support the use of tachypnoea as a clinical sign for mortality risk in young infants.

Related Resources & Content

  1. Clinical Signs Associated With Mortality and Sepsis in Young Infants: A Systematic Review and Meta-Analysis | Pediatrics | JAMA Pediatrics | JAMA Network

  2. Intensive Care Medicine — Utilizing Machine Learning to Forecast Sepsis: A Comprehensive Review and Meta-Analysis of Diagnostic Accuracy

  3. Frontiers in Pediatrics — Diagnostic accuracy of lung ultrasound for transient tachypnea of the newborn: a meta-analysis

  4. International Journal of Infectious Diseases — Mortality Risk Prediction from Dense PICU Data from Patients with Suspected Infection: Data-Derived Physiological Trajectories Outperform Expert Assessments When Temporal Resolution Is High

  5. Frontiers in Medicine — Prediction models for mortality in patients with sepsis: a systematic review and meta-analysis

  6. WHO recommendations for management of serious bacterial infections in infants aged 0–59 days

  7. https://cdn.who.int/media/docs/default-source/mca-documents/child/imci-integrated-management-of-childhood-illness/imci-in-service-training/imci_in_servicetraining_mod05.pdf?sfvrsn=29d4b3bd_6

  8. WHO recommendations

  9. Clinical Signs Associated With Mortality and Sepsis in Young Infants: A Systematic Review and Meta-Analysis | Pediatrics | JAMA Pediatrics | JAMA Network

  10. Accuracy of Infant Clinical Signs to Predict Young Infant Mortality

  11. Update to the Neonatal Early-Onset Sepsis Calculator Utilizing a Contemporary Cohort | Pediatrics | American Academy of Pediatrics

Original Source(s)

Related Content